Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Juqi Nuomei (Chongqing Juqi Nuomei Pharmaceutical Co., Ltd.) is a Chinese pharmaceutical manufacturer established in 2006 and headquartered in Chongqing. The company is primarily engaged in the research, development, and production of traditional Chinese medicines (TCM), chemical drug formulations, and active pharmaceutical ingredients (APIs). Its commercial portfolio includes respiratory treatments such as Ambroxol Hydrochloride, cardiovascular supplements like Tianwang Buxin, and gastrointestinal products. Juqi Nuomei operates GMP-certified production facilities in the Zhong County Industrial Park and holds multiple patents for drug formulations and processing technologies. The company is recognized as a national high-tech enterprise and focuses on providing healthcare solutions for both domestic consumption and international export.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Juqi Nuomei.